Erratum: Identification of ATP synthase as a lipid peroxide protein adduct in pancreatic islets from humans with and without type 2 diabetes mellitus (Journal of Clinical Endocrinology and Metabolism (2013) 98, (E727-E731) DOI: 10.1210/jc.2012-4203);Identification of ATP synthase as a lipid peroxide protein adduct in pancreatic islets from humans with and without type 2 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages 3091-

  MacDonald, M J ^a   Langberg, E C ^c   Tibell, A ^c   Sabat, G ^b   Kendrick, M A ^a   Szweda, L I ^d   Ostenson, C G ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; LIPID PEROXIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL FRACTIONATION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INSULINOMA; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; TANDEM MASS SPECTROMETRY; TISSUE INJURY;

EID: 84876252001     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2189     Document Type: Erratum

References (20)

1. Brissova M, Fowler MJ, Nicholson W.E., et al Assessment of human pancreatic islet architecture and comparison by laser scanning con-focal microscopy. J Histochem Cyto Chem. 2005; 53:1097-1097.
2. Cabrera O, Berman DM, Kenyon N.S., Ricordi C., Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA. 2006; 103:2334-2339.
3. MacDonald MJ, Longacre MJ, Stoker S.W., et al Differences between human and rodent pancreatic islets: low pyruvate carboxylase, ATP citrate lyase and pyruvate carboxylation; high glucose-stimulated acetoacetate in human pancreatic islets. J Biol Chem. 2011; 286: 18383-18396.
4. MacDonald MJ. Differences between mouse and rat pancreatic islets: succinate responsiveness, malic enzyme, and anaplerosis. Am J Physiol Endocrinol Metab. 2002; 283:E302-E310.
5. Lee Y, Hirose H, Ohneda M., Johnson JH, McGarry JD, Unger RH β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-/3-cell relationships. Proc Natl Acad Sci USA. 1994; 91:10878-10882.
6. Sako Y, Grill V. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology. 1990; 127:1580-1589.
7. Kashyap S, Belfort R Gastaldelli A, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes. 2003; 52:2461-2474.
8. Robertson RP, Harmon J, Tran P.O., Poitout V. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004; 53:S119-S124.
9. Muoio DM, Newgard CB Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008; 9:193-205.
10. Prentki M, Madiraju SR Glycerolipid metabolism and signaling in health and disease. Endocr Rev. 2008; 29:647-676.
11. Pi J, Bai Y, Zhang Q., et al Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes. 2007; 56:1783-1791.
12. Ostenson CG, Gaisano H, Sheu L., Tibell A, Bartfai T. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes. 2006; 55:435-440.
13. 0. J Biol Chem. 2004; 279:27278-27285.
14. MacDonald MJ. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets: further implication of cytosolic NADPH in insulin secretion. J Biol Chem. 1995; 270:20051-20058.
15. Cohn JA, Tsai L, Friguet B., Szweda LI Chemical characterization of a protein-4-hydroxy-2-nonenal cross link: immunochemical detection in mitochondria exposed to oxidative stress. Arch Biochem Biophys. 1996; 328:158-164.
16. Humphries KM, Szweda LI Selective inactivation of a-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry. 1998; 37:15835-15841.
17. Schneider C, Tallman KA, Porter N.A., Brash AR Two distinct pathways of formation of 4-hydroxynonenal. J Biol Chem. 2001; 276: 20831-20838.
18. Bennaars-Eiden A., Higgins L, Hertzel A.V., Kapphahn RJ, Ferrington DA, Bernlohr DA Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J Biol Chem. 2002; 277:50693-50702.
19. Miwa I, Ichimura N, Sugiura M., Hamada Y, Taniguchi S. Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology. 2000; 141:2767-2772.
20. Suarez-Pinzon W.L., Strynadka K, Rabinovitch A. Destruction of rat pancreatic β-cells by cytokines involves the production of cytotoxic aldehydes. Endocrinology. 1996; 137:5290-5296.